Kattan JG - Search Results

1

Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC).

Kattan JG, Farhat FS, Chahine GY, Nasr FL, Moukadem WT, Younes FC, Yazbeck NJ, Ghosn MG; Cancer Research Group. Kattan JG, et al. Invest New Drugs. 2008 Feb;26(1):75-9. doi: 10.1007/s10637-007-9074-3. Epub 2007 Sep 6. Invest New Drugs. 2008. PMID: 17846704 Clinical Trial.

2

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles.

Kattan J, Droz JP, Couvreur P, Marino JP, Boutan-Laroze A, Rougier P, Brault P, Vranckx H, Grognet JM, Morge X, et al. Kattan J, et al. Invest New Drugs. 1992 Aug;10(3):191-9. doi: 10.1007/BF00877245. Invest New Drugs. 1992. PMID: 1428729 Clinical Trial.

3

Phase II trial of pirarubicin in the treatment of advanced bladder cancer.

Mahjoubi M, Kattan J, Ghosn M, Droz JP, Philippot I, Herait P. Mahjoubi M, et al. Invest New Drugs. 1992 Nov;10(4):317-21. doi: 10.1007/BF00944188. Invest New Drugs. 1992. PMID: 1487407 Clinical Trial.

4

[Primary, highly malignant B-cell lymphoma of the prostate. Apropos of a case and review of the literature].

Mounedji-Boudiaf L, Culine S, Devoldère G, Terrier-Lacombe MJ, Kattan J, Cazier A, Farhat F, Bekradda M, Droz JP. Mounedji-Boudiaf L, et al. Bull Cancer. 1994 Apr;81(4):334-7. Bull Cancer. 1994. PMID: 7703552 Review. French.

5

Phase II trial of LY 186641 in advanced renal cancer.

Mahjoubi M, Kattan J, Bonnay M, Schmitt H, Droz JP. Mahjoubi M, et al. Invest New Drugs. 1993 Nov;11(4):323-8. doi: 10.1007/BF00874431. Invest New Drugs. 1993. PMID: 7726992 Clinical Trial.

6

[Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].

Abs L, Kattan J, Culine S, Bekradda M, Farhat F, Droz JP. Abs L, et al. Bull Cancer. 1994 Oct;81(10):871-6. Bull Cancer. 1994. PMID: 7734770 French.

7

[Efficacy of the combination of 5 fluorouracil, adriamycin and cisplatin (FAP protocol) in the treatment of metastatic cylindroma. Apropos of a case with review of the literature].

Farhat F, Kattan J, Culine S, Bekradda M, Droz JP. Farhat F, et al. Bull Cancer. 1994 Jan;81(1):47-50. Bull Cancer. 1994. PMID: 7949584 Review. French.

8

Super-high-risk germ-cell tumors: a clinical entity. Report of eleven cases.

Moran-Ribon A, Droz JP, Kattan J, Leclercq B, Ghosn M, Couanet D, Ostronoff M, Culine S, Misset B, Escudier B, et al. Moran-Ribon A, et al. Support Care Cancer. 1994 Jul;2(4):253-8. doi: 10.1007/BF00365732. Support Care Cancer. 1994. PMID: 8087445 Free article.

9

Cancer in the elderly. A special and unique entity.

Kattan J, Ghosn M. Kattan J, et al. J Med Liban. 1997;45(3):172-3. J Med Liban. 1997. PMID: 9396204 Review. No abstract available.

10

Evaluation of estramustine phosphate combined with weekly doxorubicin in patients with androgen-independent prostate cancer.

Culine S, Kattan J, Zanetta S, Théodore C, Fizazi K, Droz JP. Culine S, et al. Am J Clin Oncol. 1998 Oct;21(5):470-4. doi: 10.1097/00000421-199810000-00010. Am J Clin Oncol. 1998. PMID: 9781602 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters